← All indications
Neoplasms, Squamous Cell
Neoplasms of the SQUAMOUS EPITHELIAL CELLS. The concept does not refer to neoplasms located in tissue composed of squamous elements.
Subtype terms (5)
More specific conditions that are subtypes of Neoplasms, Squamous Cell in the MeSH hierarchy.
- Acanthoma
- Carcinoma, Papillary
- Carcinoma, Squamous Cell
373 drugs (153 approved, 220 experimental)
- Carcinoma, Verrucous
60 drugs (38 approved, 22 experimental)
- Papilloma
21 drugs (12 approved, 9 experimental)
Drugs by status
Phase 4 trials (1)
Phase 3 trials (6)
Phase 2 trials (17)
Phase 1 trials (12)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (18)
- Amgen
- Genmab
- Merck
- AIO-Studien-gGmbH
- Shanghai Junshi Bioscience Co.,Ltd.
- Aarhus University
- Blokhin's Russian Cancer Research Center
- Danish Head and Neck Cancer Group
- Medical University of Lublin
- Nanjing Medical University
- Soochow University
- Université catholique de Louvain
- European Organisation for Research and Treatment of Cancer
- Sun Yat-Sen University
- Viventia Biotech Inc.
- Assign Clinical Research GmbH
- Wuxi Cancer Hospital
- Government of Poland
Organization Involved with Phase 2 Indications (52)
- Bristol-Myers Squibb
- OSI Pharmaceuticals
- Imclone
- AstraZeneca
- Eli Lilly
- Genentech
- Merck KGaA
- Aventis
- Pfizer
- Novartis
- Bayer
- GlaxoSmithKline
- Hengrui Therapeutics, Inc.
- Innogene Kalbiotech Pte. Ltd
- Inovio Pharmaceuticals
- Boehringer Ingelheim
- National Cancer Institute (NCI)
- University of Pennsylvania
- University of Arizona
- University of Pittsburgh
- Anhui Medical University
- Case Western Reserve University
- Cornell University
- Eastern Cooperative Oncology Group
- Duke University
- Emory University
- Medical College of Wisconsin
- New York University
- University of Heidelberg
- University of Kansas
- +22 more
Organization Involved with Phase 1 Indications (28)
- AbbVie
- Seattle Genetics
- Schering-Plough
- MedImmune
- Infinity Pharmaceuticals, Inc.
- MultiVir, Inc.
- American Society of Clinical Oncology
- Baylor University
- Harvard University
- Temple University
- Providence Health & Services
- Stanford University
- Summa Health System
- Thomas Jefferson University
- University of Iowa
- University of Nebraska
- University of Rochester
- Wake Forest University
- William Marsh Rice University
- University of Virginia
- Galera Therapeutics
- Allegheny Health Network
- Cancer Specialists of South Texas, P.A.
- Cancer Care Northwest
- Lakeland Regional Medical Center
- BioMimetix Pharmaceutical, Inc.
- Memorial Sloan-Kettering Cancer Center
- Theraclion
Organization Involved with Other Experimental Indications (8)